Search results
UTSW studies clarify link between exercise, risk o | Newswise
Newswise· 23 hours agoJune 06, 2024 – Exercising at a high level doesn’t affect the progression of calcium buildup in the...
46 Years of HORT 201
The Bryan-College Station Eagle· 2 days agoThe class is a staple lecture course in the Texas A&M College of Agriculture and Life Sciences Department of Horticultural Sciences, covering topics on...
Health Brief - The Washington Post
Washington Post· 3 days agoAnalysisFour questions for today’s Fauci hearingThe longtime infectious-disease expert is back on Capitol Hill to testify publicly for the first time since leaving the federal government in ...
'Outstanding' 5 Year PFS With Lorlatinib in ALK+ NSCLC
Medscape· 6 days agoFive-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.
Never too late: WWII veteran, 100, to marry fiancee, 96, near Normandy beach
Sun-Sentinel· 3 days agoIt’s one of the many reasons his fiancee, Jeanne Swerlin, 96, is marrying him. “He’s such a good...
Stony Brook University Appoints Dr. Michael Kinch | Newswise
Newswise· 4 days agoSTONY BROOK, NY—June 3, 2024— Stony Brook University announced today that Michael Kinch, PhD, has...
ESHG: Parental Mosaicism Raises Recurrence Risk in Families With Presumed De Novo Variant Disorders
GenomeWeb News· 3 days agoFamilies with a child diagnosed with a rare genetic disorder presumed to stem from a de novo variant might have a higher-than-expected risk of having a second child with the same condition because ...
ESHG: Short-Read Genome Sequencing Boosts Rare Disease Diagnoses in European Solve-RD Project
GenomeWeb News· 4 days agoAccording to Steven Laurie, a data analyst at the National Center for Genomic Analysis (CNAG) in Spain, 90 out of 836 or about 10 percent of families who were...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoNeurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine PR Newswire SAN DIEGO, June 3, 2024 - CAHtalyst™ Pediatric
'Disturbing' surge in young cancers may be linked to gut health, say experts
Daily Express· 4 days agoUnhealthy lifestyles, an obesity epidemic and poor gut health are feared to be fuelling a...
